Reference number : 033-2011-2012-Q4-509298, amendment number : , agreement type : C, recipient legal name : Profound Medical Corp., recipient country : CA, recipient province : ON, recipient city : Mississauga, recipient postal code : M4N3N1, program name english : Federal Economic Development Department for Ontario, program name french : Federal Economic Development Department for Ontario, program purpose english : nan, program purpose french : nan, agreement title english : 509298, agreement title french : 509298, agreement number : 509298, agreement value : 867000.0, agreement start date : 2011-10-18, agreement end date : 2013-12-31, description english : Pre-Clinical Development and Human Clinical Trial of an MRI compatible medical device for treatment of prostate cancer, with long-term objectives of accelerating market entry into the US and Europe., description french : sans object, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : ic, owner organization title : Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada